Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

Источник: Nasdaq GlobeNewswire / 28 ноя 2023 05:59:00   America/Chicago